Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
US11014963B2 · kind B2 · utility
0Cited by
2References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2018 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Sep 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0827
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides novel compounds having the general formula (I) wherein R2, R3, R4, R5, R6, R7, R3, R8, R10, R11 and R23 are as described herein, compositions including the compounds and methods of using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.